← Leaderboards
Anne L Coleman
University Of Arkansas Med Scis Ltl Rock
$4,969,854
Attributed
$4,969,854
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $671.3K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$4,969,854 · 5
By mechanism
U10$4,969,854 · 2
M01$0 · 2
P60$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical TrialsGlaucomaCooperative StudyHuman Therapy EvaluationQuality Of LifeOcular HypotensiveClinical ResearchHuman Old Age (65+)Macular DegenerationEye Disorder ChemotherapyPilocarpineCataract SurgeryDisease /Disorder Proneness /RiskPathologic ProcessAlcoholism /Alcohol AbuseDietDiabetes MellitusFemaleHip FracturesAccidental FallsEye Fundus PhotographyEstrogensHuman Population Study
Grant awards (18)
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$123,719
U10 · FY2008 · EY · contact PI
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$120,913
U10 · FY2007 · EY · contact PI
Incidence of late macular degeneration in older women$399,067
U10 · FY2006 · EY · contact PI
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$118,187
U10 · FY2006 · EY · contact PI
Incidence of late macular degeneration in older women$556,120
U10 · FY2005 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$115,210
U10 · FY2005 · EY
Incidence of late macular degeneration in older women$606,974
U10 · FY2004 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$122,045
U10 · FY2004 · EY
Incidence of late macular degeneration in older women$970,241
U10 · FY2003 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$172,658
U10 · FY2003 · EY
Incidence of late macular degeneration in older women$1,204,380
U10 · FY2002 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$166,535
U10 · FY2002 · EY
MULTIDIMENSIONAL INTERVENTION FOR VISION-IMPAIRED ELDERS$0
P60 · FY2002 · AG
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$148,603
U10 · FY2001 · EY
MULTIDIMENSIONAL INTERVENTION FOR VISION-IMPAIRED ELDERS$0
P60 · FY2001 · AG
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$145,202
U10 · FY2000 · EY
Aerobic &Strength Building Exercise Before /During Chemotherapy$0
M01 · FY2000 · RR
Exercise Study for Patients with Multiple Myeloma$0
M01 · FY2000 · RR